140 related articles for article (PubMed ID: 3119776)
1. Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease.
Guiloff RJ; Eckland DJ; Demaine C; Hoare RC; MacRae KD; Lightman SL
J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1359-70. PubMed ID: 3119776
[TBL] [Abstract][Full Text] [Related]
2. Observations on the clinical assessment of patients with motor neuron disease. Experience with a TRH analogue.
Guiloff RJ; Eckland DJ
Neurol Clin; 1987 Feb; 5(1):171-92. PubMed ID: 3104752
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of intravenous and oral administration of a TRH analogue (RX77368) in motor neuron disease.
Modarres-Sadeghi H; Guiloff RJ
J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):944-7. PubMed ID: 2126554
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368).
Guiloff RJ; Stålberg E; Eckland DJ; Lightman SL
J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1633-40. PubMed ID: 3125307
[TBL] [Abstract][Full Text] [Related]
5. Subacute administration of a TRH analogue (RX77368) in motorneuron disease: an open study.
Modarres-Sadeghi H; Rogers H; Emami J; Guiloff RJ
J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1146-57. PubMed ID: 3147318
[TBL] [Abstract][Full Text] [Related]
6. The effects of repeated administration of a long acting TRH analogue (RX77368), on TSH, T4, T3 and prolactin in patients with motor neuron disease.
Eckland DJ; Modarres-Sadeghi H; Lightman SL; Guiloff RJ
J Neurol Neurosurg Psychiatry; 1990 Sep; 53(9):803-4. PubMed ID: 2123237
[No Abstract] [Full Text] [Related]
7. Short-term stability of single motor unit recordings in motor neuron disease: a macro EMG study.
Guiloff RJ; Modarres-Sadeghi H; Stålberg E; Rogers H
J Neurol Neurosurg Psychiatry; 1988 May; 51(5):671-6. PubMed ID: 3136230
[TBL] [Abstract][Full Text] [Related]
8. Continuous response variable trial design in motor neuron disease: long term treatment with a TRH analogue (RX77368).
Goonetilleke A; Guiloff RJ
J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):201-8. PubMed ID: 7876852
[TBL] [Abstract][Full Text] [Related]
9. Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.
Clarke KA; Stirk G
Br J Pharmacol; 1983 Nov; 80(3):561-5. PubMed ID: 6416344
[TBL] [Abstract][Full Text] [Related]
10. Use of TRH analogues in motorneurone disease.
Guiloff RJ
Ann N Y Acad Sci; 1989; 553():399-421. PubMed ID: 2497683
[TBL] [Abstract][Full Text] [Related]
11. Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.
Ballard TM; Hunter AJ; Bennett GW
Psychopharmacology (Berl); 1996 Oct; 127(3):265-75. PubMed ID: 8912405
[TBL] [Abstract][Full Text] [Related]
12. Development of a radioimmunoassay for RX77368 (pGlu-His-3,3-dimethyl proline amide)--a stable analogue of thyrotrophin releasing hormone (TRH).
Lynn AG; Bennett GW
J Pharm Biomed Anal; 1991; 9(1):9-18. PubMed ID: 1904280
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin-releasing hormone (TRH) in murine motor neuron disease (the wobbler mouse).
Kozachuk WE; Mitsumoto H; Salanga VD; Beck GJ; Wilber JF
J Neurol Sci; 1987 May; 78(3):253-60. PubMed ID: 3108458
[TBL] [Abstract][Full Text] [Related]
14. Effects of an analogue of thyrotrophin-releasing hormone, RX77368, on infarct size and cerebral blood flow in focal cerebral ischaemia in the rat.
O'Shaughnessy CT; Rothwell NJ; Shrewsbury-Gee J
Can J Physiol Pharmacol; 1989 Oct; 67(10):1345-50. PubMed ID: 2514979
[TBL] [Abstract][Full Text] [Related]
15. Motoneurone excitability during antidromically evoked inhibition after administration of a thyrotrophin releasing hormone (TRH) analogue.
Clarke KA; Parker AJ; Stirk GC
Neuropeptides; 1984 Sep; 4(5):403-11. PubMed ID: 6436727
[TBL] [Abstract][Full Text] [Related]
16. Effects of a thyrotropin releasing hormone analogue on locomotor and other motor activity in the rat.
Clarke KA; Parker AJ
Neuropeptides; 1985 Apr; 6(2):101-12. PubMed ID: 3923383
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the motor behaviours produced by the intrathecal administration of thyrotrophin-releasing hormone and thyrotrophin-releasing hormone analogues in the conscious rat.
Johnson JV; Fone KC; Havler ME; Tulloch IF; Bennett GW; Marsden CA
Neuroscience; 1989; 29(2):463-70. PubMed ID: 2498761
[TBL] [Abstract][Full Text] [Related]
18. The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers.
Coupland NJ; Bailey JE; Glue P; Nutt DJ
Br J Clin Pharmacol; 1995 Sep; 40(3):223-9. PubMed ID: 8527283
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of motor neuron diseases using intrathecal TRH. Pilot study I].
Patrignani Ochoa J; Morales Martínez D; Martínez Parra C
Neurologia; 1988; 3(6):221-5. PubMed ID: 3152558
[No Abstract] [Full Text] [Related]
20. Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain?
Metcalf G; Dettmar PW
Lancet; 1981 Mar; 1(8220 Pt 1):586-9. PubMed ID: 6110823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
